Pascual Sanz - Publications

Affiliations: 
Instituto de Biomedicina de Valencia, València, Comunidad Valenciana, Spain 

63/94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mollá B, Heredia M, Sanz P. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model. Molecular Neurobiology. PMID 33447969 DOI: 10.1007/s12035-021-02285-1  0.36
2020 Perez-Jimenez E, Viana R, Muñoz-Ballester C, Vendrell-Tornero C, Moll-Diaz R, Garcia-Gimeno MA, Sanz P. Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease. Glia. PMID 33368637 DOI: 10.1002/glia.23956  0.8
2020 Aso E, Andrés-Benito P, Grau-Escolano J, Caltana L, Brusco A, Sanz P, Ferrer I. Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model. Cannabis and Cannabinoid Research. 5: 150-163. PMID 32656347 DOI: 10.1089/can.2019.0005  0.36
2020 Sanz P, Garcia-Gimeno MA. Reactive Glia Inflammatory Signaling Pathways and Epilepsy. International Journal of Molecular Sciences. 21. PMID 32521797 DOI: 10.3390/ijms21114096  0.8
2020 Gentry MS, Afawi Z, Armstrong DD, Delgado-Escueta A, Goldberg YP, Grossman TR, Guinovart JJ, Harris F, Hurley TD, Michelucci R, Minassian BA, Sanz P, Worby CA, Serratosa JM. The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic. Epilepsy & Behavior : E&B. 106839. PMID 31932179 DOI: 10.1016/J.Yebeh.2019.106839  0.4
2019 Lahuerta M, Gonzalez D, Aguado C, Fathinajafabadi A, García-Giménez JL, Moreno-Estellés M, Romá-Mateo C, Knecht E, Pallardó FV, Sanz P. Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age. Molecular Neurobiology. PMID 31808062 DOI: 10.1007/s12035-019-01842-z  0.48
2019 Sanchez-Martin P, Lahuerta M, Viana R, Knecht E, Sanz P. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease. Biochimica Et Biophysica Acta. Molecular Cell Research. 1867: 118613. PMID 31758957 DOI: 10.1016/j.bbamcr.2019.118613  0.8
2019 Muñoz-Ballester C, Santana N, Perez-Jimenez E, Viana R, Artigas F, Sanz P. In vivo glutamate clearance defects in a mouse model of Lafora disease. Experimental Neurology. 112959. PMID 31108086 DOI: 10.1016/j.expneurol.2019.112959  0.8
2018 Garcia-Gimeno MA, Rodilla-Ramirez PN, Viana R, Salas-Puig X, Brewer MK, Gentry MS, Sanz P. A novel EPM2A mutation yields a slow progression form of Lafora disease. Epilepsy Research. 145: 169-177. PMID 30041081 DOI: 10.1016/J.Eplepsyres.2018.07.003  0.8
2018 Lahuerta M, Aguado C, Sánchez-Martín P, Sanz P, Knecht E. Degradation of altered mitochondria by autophagy is impaired in Lafora disease. The Febs Journal. 285: 2071-2090. PMID 29645350 DOI: 10.1111/febs.14468  0.48
2018 Sanz P, Viana R, Garcia-Gimeno MA. AMPK Protein Interaction Analyses by Yeast Two-Hybrid. Methods in Molecular Biology (Clifton, N.J.). 1732: 143-157. PMID 29480473 DOI: 10.1007/978-1-4939-7598-3_9  0.8
2018 Rubio-Villena C, Viana R, Bonet J, Garcia-Gimeno MA, Casado M, Heredia M, Sanz P. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Human Molecular Genetics. PMID 29408991 DOI: 10.1093/hmg/ddy044  0.8
2017 Qian J, García-Gimeno MA, Beullens M, Manzione MG, Van der Hoeven G, Igual JC, Heredia M, Sanz P, Gelens L, Bollen M. An Attachment-Independent Biochemical Timer of the Spindle Assembly Checkpoint. Molecular Cell. 68: 715-730.e5. PMID 29129638 DOI: 10.1016/j.molcel.2017.10.011  0.36
2017 López-González I, Viana R, Sanz P, Ferrer I. Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models. Molecular Neurobiology. 54: 3119-3130. PMID 27041370 DOI: 10.1007/s12035-016-9884-4  0.8
2016 Sanz P, Viana R, Garcia-Gimeno MA. AMPK in Yeast: The SNF1 (Sucrose Non-fermenting 1) Protein Kinase Complex. Experientia Supplementum (2012). 107: 353-374. PMID 27812987 DOI: 10.1007/978-3-319-43589-3_14  0.8
2016 Romá-Mateo C, Raththagala M, Gentry MS, Sanz P. Assessing the Biological Activity of the Glucan Phosphatase Laforin. Methods in Molecular Biology (Clifton, N.J.). 1447: 107-19. PMID 27514803 DOI: 10.1007/978-1-4939-3746-2_7  0.48
2016 Muñoz-Ballester C, Berthier A, Viana R, Sanz P. Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease. Biochimica Et Biophysica Acta. 1862: 1074-83. PMID 26976331 DOI: 10.1016/j.bbadis.2016.03.008  0.8
2016 Oligschlaeger Y, Miglianico M, Dahlmans V, Rubio-Villena C, Chanda D, García-Gimeno MA, Coumans WA, Liu Y, Voncken JW, Luiken JJ, Glatz JF, Sanz P, Neumann D. The interaction between AMPKβ2 and the PP1-targeting subunit R6 is dynamically regulated by intracellular glycogen content. The Biochemical Journal. PMID 26831516 DOI: 10.1042/BJ20151035  0.8
2015 Sánchez-Martín P, Romá-Mateo C, Viana R, Sanz P. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex. The International Journal of Biochemistry & Cell Biology. 69: 204-14. PMID 26546463 DOI: 10.1016/j.biocel.2015.10.030  0.8
2015 Viana R, Lujan P, Sanz P. The laforin/malin E3-ubiquitin ligase complex ubiquitinates pyruvate kinase M1/M2. Bmc Biochemistry. 16: 24. PMID 26493215 DOI: 10.1186/s12858-015-0053-6  0.8
2015 Rubio-Villena C, Sanz P, Garcia-Gimeno MA. Structure-Function Analysis of PPP1R3D, a Protein Phosphatase 1 Targeting Subunit, Reveals a Binding Motif for 14-3-3 Proteins which Regulates its Glycogenic Properties. Plos One. 10: e0131476. PMID 26114292 DOI: 10.1371/journal.pone.0131476  0.8
2015 Romá-Mateo C, Aguado C, García-Giménez JL, Knecht E, Sanz P, Pallardó FV. Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy. Free Radical Biology & Medicine. 88: 30-41. PMID 25680286 DOI: 10.1016/j.freeradbiomed.2015.01.034  0.48
2015 Berthier A, Payá M, García-Cabrero AM, Ballester MI, Heredia M, Serratosa JM, Sánchez MP, Sanz P. Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease. Molecular Neurobiology. PMID 25627694 DOI: 10.1007/s12035-015-9091-8  0.56
2015 Raththagala M, Brewer MK, Parker MW, Sherwood AR, Wong BK, Hsu S, Bridges TM, Paasch BC, Hellman LM, Husodo S, Meekins DA, Taylor AO, Turner BD, Auger KD, Dukhande VV, ... ... Sanz P, et al. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease. Molecular Cell. 57: 261-72. PMID 25544560 DOI: 10.1016/J.Molcel.2014.11.020  0.4
2015 Romá-Mateo C, Aguado C, García-Giménez JL, Ibáñez-Cabellos JS, Seco-Cervera M, Pallardó FV, Knecht E, Sanz P. Increased oxidative stress and impaired antioxidant response in Lafora disease. Molecular Neurobiology. 51: 932-46. PMID 24838580 DOI: 10.1007/s12035-014-8747-0  0.48
2014 Romá-Mateo C, Aguado C, García-Giménez JL, Ibáñez-Cabellos JS, Seco-Cervera M, Pallardó FV, Knecht E, Sanz P. Increased oxidative stress and impaired antioxidant response in Lafora disease. Free Radical Biology & Medicine. 75: S47. PMID 26461389 DOI: 10.1016/j.freeradbiomed.2014.10.809  0.48
2013 Sánchez-Martín P, Raththagala M, Bridges TM, Husodo S, Gentry MS, Sanz P, Romá-Mateo C. Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329. Plos One. 8: e69523. PMID 23922729 DOI: 10.1371/Journal.Pone.0069523  0.48
2013 García-Giménez JL, Seco-Cervera M, Aguado C, Romá-Mateo C, Dasí F, Priego S, Markovic J, Knecht E, Sanz P, Pallardó FV. Lafora disease fibroblasts exemplify the molecular interdependence between thioredoxin 1 and the proteasome in mammalian cells. Free Radical Biology & Medicine. 65: 347-359. PMID 23850970 DOI: 10.1016/j.freeradbiomed.2013.07.001  0.48
2013 Sanz P, Rubio T, Garcia-Gimeno MA. AMPKβ subunits: more than just a scaffold in the formation of AMPK complex. The Febs Journal. 280: 3723-33. PMID 23721051 DOI: 10.1111/febs.12364  0.8
2013 Rubio-Villena C, Garcia-Gimeno MA, Sanz P. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. The International Journal of Biochemistry & Cell Biology. 45: 1479-88. PMID 23624058 DOI: 10.1016/j.biocel.2013.04.019  0.8
2013 Rubio T, Vernia S, Sanz P. Sumoylation of AMPKβ2 subunit enhances AMP-activated protein kinase activity. Molecular Biology of the Cell. 24: 1801-11, S1-4. PMID 23552691 DOI: 10.1091/mbc.E12-11-0806  0.6
2013 Gentry MS, Romá-Mateo C, Sanz P. Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. The Febs Journal. 280: 525-37. PMID 22364389 DOI: 10.1111/J.1742-4658.2012.08549.X  0.48
2012 Garcia-Haro L, Garcia-Gimeno MA, Neumann D, Beullens M, Bollen M, Sanz P. Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathway. Febs Letters. 586: 4241-7. PMID 23116618 DOI: 10.1016/j.febslet.2012.10.032  0.8
2012 Romá-Mateo C, Sanz P, Gentry MS. Deciphering the role of malin in the lafora progressive myoclonus epilepsy. Iubmb Life. 64: 801-8. PMID 22815132 DOI: 10.1002/Iub.1072  0.48
2012 Knecht E, Criado-García O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Millán B, Heredia M, Romá-Mateo C, Mouron S, Juana-López L, Domínguez M, Navarro C, Serratosa JM, ... ... Sanz P, et al. Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora disease. Autophagy. 8: 701-3. PMID 22361617 DOI: 10.4161/auto.19522  0.6
2012 García-Giménez JL, Ledesma AM, Esmoris I, Romá-Mateo C, Sanz P, Viña J, Pallardó FV. Histone carbonylation occurs in proliferating cells. Free Radical Biology & Medicine. 52: 1453-64. PMID 22342519 DOI: 10.1016/j.freeradbiomed.2012.01.022  0.48
2012 Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Millán B, Heredia M, Romá-Mateo C, Mouron S, Juana-López L, Domínguez M, Navarro C, Serratosa JM, Sanchez M, ... Sanz P, et al. Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Human Molecular Genetics. 21: 1521-33. PMID 22186026 DOI: 10.1093/hmg/ddr590  0.6
2011 Dukhande VV, Rogers DM, Romá-Mateo C, Donderis J, Marina A, Taylor AO, Sanz P, Gentry MS. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. Plos One. 6: e24040. PMID 21887368 DOI: 10.1371/Journal.Pone.0024040  0.48
2011 Romá-Mateo C, Moreno D, Vernia S, Rubio T, Bridges TM, Gentry MS, Sanz P. Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level. Bmc Evolutionary Biology. 11: 225. PMID 21798009 DOI: 10.1186/1471-2148-11-225  0.6
2011 Guerrero R, Vernia S, Sanz R, Abreu-Rodríguez I, Almaraz C, García-Hoyos M, Michelucci R, Tassinari CA, Riguzzi P, Nobile C, Sanz P, Serratosa JM, Gómez-Garre P. A PTG variant contributes to a milder phenotype in Lafora disease. Plos One. 6: e21294. PMID 21738631 DOI: 10.1371/journal.pone.0021294  0.6
2011 Romá-Mateo C, Solaz-Fuster Mdel C, Gimeno-Alcañiz JV, Dukhande VV, Donderis J, Worby CA, Marina A, Criado O, Koller A, Rodriguez De Cordoba S, Gentry MS, Sanz P. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase. The Biochemical Journal. 439: 265-75. PMID 21728993 DOI: 10.1042/Bj20110150  0.48
2011 Couarch P, Vernia S, Gourfinkel-An I, Lesca G, Gataullina S, Fedirko E, Trouillard O, Depienne C, Dulac O, Steschenko D, Leguern E, Sanz P, Baulac S. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism. Journal of Molecular Medicine (Berlin, Germany). 89: 915-25. PMID 21505799 DOI: 10.1007/s00109-011-0758-y  0.6
2011 Vernia S, Heredia M, Criado O, Rodriguez de Cordoba S, Garcia-Roves PM, Cansell C, Denis R, Luquet S, Foufelle F, Ferre P, Sanz P. Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice. Human Molecular Genetics. 20: 2571-84. PMID 21493628 DOI: 10.1093/hmg/ddr157  0.6
2010 Knecht E, Aguado C, Sarkar S, Korolchuk VI, Criado-García O, Vernia S, Boya P, Sanz P, Rodríguez de Córdoba S, Rubinsztein DC. Impaired autophagy in Lafora disease. Autophagy. 6: 991-3. PMID 20818165 DOI: 10.4161/auto6.7.13308  0.6
2010 Garcia-Haro L, Garcia-Gimeno MA, Neumann D, Beullens M, Bollen M, Sanz P. The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 5080-91. PMID 20724523 DOI: 10.1096/fj.10-166306  0.8
2010 Moreno D, Towler MC, Hardie DG, Knecht E, Sanz P. The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits. Molecular Biology of the Cell. 21: 2578-88. PMID 20534808 DOI: 10.1091/mbc.E10-03-0227  0.56
2010 Aguado C, Sarkar S, Korolchuk VI, Criado O, Vernia S, Boya P, Sanz P, de Córdoba SR, Knecht E, Rubinsztein DC. Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Human Molecular Genetics. 19: 2867-76. PMID 20453062 DOI: 10.1093/hmg/ddq190  0.6
2009 Barbetti F, Cobo-Vuilleumier N, Dionisi-Vici C, Toni S, Ciampalini P, Massa O, Rodriguez-Bada P, Colombo C, Lenzi L, Garcia-Gimeno MA, Bermudez-Silva FJ, Rodriguez de Fonseca F, Banin P, Aledo JC, Baixeras E, ... Sanz P, et al. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. Molecular Endocrinology (Baltimore, Md.). 23: 1983-9. PMID 19884385 DOI: 10.1210/me.2009-0094  0.8
2009 Moreno D, Viana R, Sanz P. Two-hybrid analysis identifies PSMD11, a non-ATPase subunit of the proteasome, as a novel interaction partner of AMP-activated protein kinase. The International Journal of Biochemistry & Cell Biology. 41: 2431-9. PMID 19616115 DOI: 10.1016/j.biocel.2009.07.002  0.8
2009 Vernia S, Rubio T, Heredia M, Rodríguez de Córdoba S, Sanz P. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. Plos One. 4: e5907. PMID 19529779 DOI: 10.1371/journal.pone.0005907  0.6
2009 Vernia S, Solaz-Fuster MC, Gimeno-Alcañiz JV, Rubio T, García-Haro L, Foretz M, de Córdoba SR, Sanz P. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex. The Journal of Biological Chemistry. 284: 8247-55. PMID 19171932 DOI: 10.1074/jbc.M808492200  0.6
2008 Moreno D, Knecht E, Viollet B, Sanz P. A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. Febs Letters. 582: 2650-4. PMID 18593584 DOI: 10.1016/j.febslet.2008.06.044  0.56
2008 Riera A, Ahuatzi D, Herrero P, Garcia-Gimeno MA, Sanz P, Moreno F. Human pancreatic beta-cell glucokinase: subcellular localization and glucose repression signalling function in the yeast cell. The Biochemical Journal. 415: 233-9. PMID 18588509 DOI: 10.1042/BJ20080797  0.8
2008 Viana R, Aguado C, Esteban I, Moreno D, Viollet B, Knecht E, Sanz P. Role of AMP-activated protein kinase in autophagy and proteasome function. Biochemical and Biophysical Research Communications. 369: 964-8. PMID 18328803 DOI: 10.1016/j.bbrc.2008.02.126  0.8
2008 Estalella I, Garcia-Gimeno MA, Marina A, Castaño L, Sanz P. Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patients. Journal of Human Genetics. 53: 460-6. PMID 18322640 DOI: 10.1007/s10038-008-0271-5  0.8
2007 Lesage B, Beullens M, Pedelini L, Garcia-Gimeno MA, Waelkens E, Sanz P, Bollen M. A complex of catalytically inactive protein phosphatase-1 sandwiched between Sds22 and inhibitor-3. Biochemistry. 46: 8909-19. PMID 17630778 DOI: 10.1021/bi7003119  0.8
2007 Viana R, Towler MC, Pan DA, Carling D, Viollet B, Hardie DG, Sanz P. A conserved sequence immediately N-terminal to the Bateman domains in AMP-activated protein kinase gamma subunits is required for the interaction with the beta subunits. The Journal of Biological Chemistry. 282: 16117-25. PMID 17403675 DOI: 10.1074/Jbc.M611804200  0.8
2007 Pedelini L, Marquina M, Ariño J, Casamayor A, Sanz L, Bollen M, Sanz P, Garcia-Gimeno MA. YPI1 and SDS22 proteins regulate the nuclear localization and function of yeast type 1 phosphatase Glc7. The Journal of Biological Chemistry. 282: 3282-92. PMID 17142459 DOI: 10.1074/jbc.M607171200  0.8
2006 Solaz-Fuster MC, Gimeno-Alcañiz JV, Casado M, Sanz P. TRIP6 transcriptional co-activator is a novel substrate of AMP-activated protein kinase. Cellular Signalling. 18: 1702-12. PMID 16624523 DOI: 10.1016/j.cellsig.2006.01.021  0.36
2005 Pedelini L, Garcia-Gimeno MA, Marina A, Gomez-Zumaquero JM, Rodriguez-Bada P, López-Enriquez S, Soriguer FC, Cuesta-Muñoz AL, Sanz P. Structure-function analysis of the alpha5 and the alpha13 helices of human glucokinase: description of two novel activating mutations. Protein Science : a Publication of the Protein Society. 14: 2080-6. PMID 15987895 DOI: 10.1110/ps.051485205  0.8
2005 Tomás-Cobos L, Viana R, Sanz P. TOR kinase pathway and 14-3-3 proteins regulate glucose-induced expression of HXT1, a yeast low-affinity glucose transporter. Yeast (Chichester, England). 22: 471-9. PMID 15849787 DOI: 10.1002/yea.1224  0.8
2004 Tomás-Cobos L, Casadomé L, Mas G, Sanz P, Posas F. Expression of the HXT1 low affinity glucose transporter requires the coordinated activities of the HOG and glucose signalling pathways. The Journal of Biological Chemistry. 279: 22010-9. PMID 15014083 DOI: 10.1074/jbc.M400609200  0.6
2002 Tomás-Cobos L, Sanz P. Active Snf1 protein kinase inhibits expression of the Saccharomyces cerevisiae HXT1 glucose transporter gene. The Biochemical Journal. 368: 657-63. PMID 12220226 DOI: 10.1042/BJ20020984  0.6
Low-probability matches
2018 García-Gimeno MA, Knecht E, Sanz P. Lafora Disease: A Ubiquitination-Related Pathology. Cells. 7. PMID 30050012 DOI: 10.3390/cells7080087  0.28
2008 Solaz-Fuster MC, Gimeno-Alcañiz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, Criado Garcia O, Vilchez D, Dominguez J, Garcia-Rocha M, Sanchez-Piris M, Aguado C, Knecht E, Serratosa J, Guinovart JJ, Sanz P, et al. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Human Molecular Genetics. 17: 667-78. PMID 18029386 DOI: 10.1093/hmg/ddm339  0.28
2003 Fernández-Sánchez ME, Criado-García O, Heath KE, García-Fojeda B, Medraño-Fernández I, Gomez-Garre P, Sanz P, Serratosa JM, Rodríguez de Córdoba S. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Human Molecular Genetics. 12: 3161-71. PMID 14532330 DOI: 10.1093/hmg/ddg340  0.28
2017 Theret M, Gsaier L, Schaffer B, Juban G, Ben Larbi S, Weiss-Gayet M, Bultot L, Caterina C, Foretz M, Desplanches D, Sanz P, Zang Z, Yang L, Vial G, Viollet B, et al. AMPKα1-LDH pathway regulates muscle stem cell self-renewal by controlling metabolic homeostasis. The Embo Journal. PMID 28515121 DOI: 10.15252/Embj.201695273  0.24
2003 Gimeno-Alcañiz JV, Sanz P. Glucose and type 2A protein phosphatase regulate the interaction between catalytic and regulatory subunits of AMP-activated protein kinase. Journal of Molecular Biology. 333: 201-9. PMID 14516753 DOI: 10.1016/j.jmb.2003.08.022  0.2
2020 Espinós C, Galindo MI, García-Gimeno MA, Ibáñez-Cabellos JS, Martínez-Rubio D, Millán JM, Rodrigo R, Sanz P, Seco-Cervera M, Sevilla T, Tapia A, Pallardó FV. Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration. Antioxidants (Basel, Switzerland). 9. PMID 32326494 DOI: 10.3390/antiox9040313  0.12
2020 Sanz P, Serratosa JM. Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities. Expert Reviews in Molecular Medicine. 22: e4. PMID 32938505 DOI: 10.1017/erm.2020.5  0.08
2017 Sánchez-Elexpuru G, Serratosa JM, Sanz P, Sánchez MP. 4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease. Neuroreport. PMID 28181916 DOI: 10.1097/WNR.0000000000000751  0.08
2003 García-Gimeno MA, Muñoz I, Ariño J, Sanz P. Molecular characterization of Ypi1, a novel Saccharomyces cerevisiae type 1 protein phosphatase inhibitor. The Journal of Biological Chemistry. 278: 47744-52. PMID 14506263 DOI: 10.1074/jbc.M306157200  0.08
2002 Mayordomo I, Estruch F, Sanz P. Convergence of the target of rapamycin and the Snf1 protein kinase pathways in the regulation of the subcellular localization of Msn2, a transcriptional activator of STRE (Stress Response Element)-regulated genes. The Journal of Biological Chemistry. 277: 35650-6. PMID 12093809 DOI: 10.1074/jbc.M204198200  0.08
2019 Sanchis A, García-Gimeno MA, Cañada-Martínez AJ, Sequedo MD, Millán JM, Sanz P, Vázquez-Manrique RP. Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease. Experimental & Molecular Medicine. 51: 65. PMID 31165723 DOI: 10.1038/s12276-019-0264-9  0.04
2016 Sendra L, Miguel A, Pérez-Enguix D, Herrero MJ, Montalvá E, García-Gimeno MA, Noguera I, Díaz A, Pérez J, Sanz P, López-Andújar R, Martí-Bonmatí L, Aliño SF. Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans. Plos One. 11: e0163898. PMID 27695064 DOI: 10.1371/journal.pone.0163898  0.04
2012 Fréville A, Landrieu I, García-Gimeno MA, Vicogne J, Montbarbon M, Bertin B, Verger A, Kalamou H, Sanz P, Werkmeister E, Pierrot C, Khalife J. Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival. The Journal of Biological Chemistry. 287: 1306-21. PMID 22128182 DOI: 10.1074/Jbc.M111.276865  0.04
2010 Kassem S, Bhandari S, Rodríguez-Bada P, Motaghedi R, Heyman M, García-Gimeno MA, Cobo-Vuilleumier N, Sanz P, Maclaren NK, Rahier J, Glaser B, Cuesta-Muñoz AL. Large islets, beta-cell proliferation, and a glucokinase mutation. The New England Journal of Medicine. 362: 1348-50. PMID 20375417 DOI: 10.1056/NEJMc0909845  0.04
2005 González-Cabo P, Vázquez-Manrique RP, García-Gimeno MA, Sanz P, Palau F. Frataxin interacts functionally with mitochondrial electron transport chain proteins. Human Molecular Genetics. 14: 2091-8. PMID 15961414 DOI: 10.1093/hmg/ddi214  0.04
2004 Cuesta-Muñoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Näntö-Salonen K, Rahier J, López-Enriquez S, García-Gimeno MA, Sanz P, Soriguer FC, Laakso M. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes. 53: 2164-8. PMID 15277402 DOI: 10.2337/diabetes.53.8.2164  0.04
2021 Kumarasinghe L, Xiong L, Garcia-Gimeno MA, Lazzari E, Sanz P, Meroni G. TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases. Cells. 10. PMID 33917450 DOI: 10.3390/cells10040820  0.01
2021 Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Sanz P, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280  0.01
2020 Gómez-Escribano A, Bono-Yagüe J, García-Gimeno M, Sequedo M, Hervás D, Fornés-Ferrer V, Torres-Sánchez S, Millán J, Sanz P, Vázquez-Manrique R. Synergistic activation of AMPK prevents from polyglutamine-induced toxicity in Caenorhabditis elegans Pharmacological Research. 161: 105105. DOI: 10.1016/j.phrs.2020.105105  0.01
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.01
2012 Knecht E, Criado-García O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Millán B, Heredia M, Romá-Mateo C, Mouron S, Juana-López L, Domínguez M, Navarro C, Serratosa JM, ... ... Sanz P, et al. Erratum to Autophagy. 8: 1163-1163. DOI: 10.4161/AUTO.21428  0.01
2009 Meissner T, Marquard J, Cobo-Vuilleumier N, Maringa M, Rodríguez-Bada P, García-Gimeno MA, Baixeras E, Weber J, Olek K, Sanz P, Mayatepek E, Cuesta-Muñoz AL. Diagnostic difficulties in glucokinase hyperinsulinism. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 41: 320-6. PMID 19053014 DOI: 10.1055/s-0028-1102922  0.01
2008 Sanz P. AMP-activated protein kinase: structure and regulation. Current Protein & Peptide Science. 9: 478-92. PMID 18855699  0.01
2007 Sanz P. Yeast as a model system to study glucose-mediated signalling and response. Frontiers in Bioscience : a Journal and Virtual Library. 12: 2358-71. PMID 17127246  0.01
2003 Mayordomo I, Regelmann J, Horak J, Sanz P. Saccharomyces cerevisiae 14-3-3 proteins Bmh1 and Bmh2 participate in the process of catabolite inactivation of maltose permease. Febs Letters. 544: 160-4. PMID 12782308 DOI: 10.1016/s0014-5793(03)00498-8  0.01
2003 Rodríguez C, Sanz P, Gancedo C. New mutations of Saccharomyces cerevisiae that partially relieve both glucose and galactose repression activate the protein kinase Snf1. Fems Yeast Research. 3: 77-84. PMID 12702249 DOI: 10.1111/J.1567-1364.2003.Tb00141.X  0.01
2003 Sanz P. Snf1 protein kinase: a key player in the response to cellular stress in yeast. Biochemical Society Transactions. 31: 178-81. PMID 12546680 DOI: 10.1042/BST0310178  0.01
2003 RODRIGUEZ C, SANZ P, GANCEDO C. New mutations of that partially relieve both glucose and galactose repression activate the protein kinase Snf1 Fems Yeast Research. 3: 77-84. DOI: 10.1016/S1567-1356(02)00156-3  0.01
2002 Mayordomo I, Sanz P. The Saccharomyces cerevisiae 14-3-3 protein Bmh2 is required for regulation of the phosphorylation status of Fin1, a novel intermediate filament protein. The Biochemical Journal. 365: 51-6. PMID 11931638 DOI: 10.1042/BJ20020053  0.01
2002 Mayordomo I, Sanz P. Human pancreatic glucokinase (GlkB) complements the glucose signalling defect of Saccharomyces cerevisiae hxk2 mutants. Yeast (Chichester, England). 18: 1309-16. PMID 11571755 DOI: 10.1002/yea.780  0.01
2001 Mayordomo I, Sanz P. Hexokinase PII: structural analysis and glucose signalling in the yeast Saccharomyces cerevisiae. Yeast (Chichester, England). 18: 923-30. PMID 11447598 DOI: 10.1002/yea.737  0.01
Hide low-probability matches.